Sun Pharma, Dr Reddy's, Zydus plan early launch In December 2025, India's largest drug maker, Sun Pharmaceutical Industries, received Drug Controller General of India (DCGI) approval for manufacturing and marketing semaglutide injection for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
Weight loss accelerates during this period, which compounds the glucose benefits
Finally, we help you make a realistic decision by clarifying the Cost of GLP-1 therapy and outlining options for long term maintenance that protect body composition and how you look and feel
Compounded semaglutide from 503A pharmacies is not FDA-approved but undergoes quality oversight
Growth hormone plays a direct role in protein synthesis and musclefiber maintenance, which is why clinicians are evaluating whether sermorelin, agrowth hormone-releasing peptide, may support better body composition outcomeswhen used alongside GLP-1 medications